UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003190 |
|---|---|
| Receipt number | R000003651 |
| Scientific Title | Cancer Vaccine Therapy using Epitope Peptide Restricted to HLA-A*02 (URLC10) in Patients with Non-small Cell Lung Cancer Refractory to Standard Therapy (Phase I study) |
| Date of disclosure of the study information | 2010/02/16 |
| Last modified on | 2019/03/31 22:37:37 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/02/16 10:43:05 | ||
| 2 | Update | 2010/02/16 16:26:44 | Anticipated trial start date |
|
| 3 | Update | 2010/02/20 19:05:21 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 4 | Update | 2012/05/04 11:42:22 | Last name of lead principal investigator Name of person sending information Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2012/05/04 11:42:46 | Type of intervention |
|
| 6 | Update | 2012/12/06 14:57:42 | Last follow-up date |
|
| 7 | Update | 2019/03/31 22:37:37 | Recruitment status Date of IRB Last follow-up date |
